Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
Blood. 2022 Oct 20;140(16):1753-1763. doi: 10.1182/blood.2021014956.
Blood. 2022.
PMID: 35512188
Free PMC article.
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells.
Sellar RS, Sperling AS, Słabicki M, Gasser JA, McConkey ME, Donovan KA, Mageed N, Adams DN, Zou C, Miller PG, Dutta RK, Boettcher S, Lin AE, Sandoval B, Quevedo Barrios VA, Kovalcik V, Koeppel J, Henderson EK, Fink EC, Yang L, Chan A, Pokharel SP, Bergstrom EJ, Burt R, Udeshi ND, Carr SA, Fischer ES, Chen CW, Ebert BL.
Sellar RS, et al. Among authors: quevedo barrios va.
J Clin Invest. 2022 Aug 15;132(16):e153514. doi: 10.1172/JCI153514.
J Clin Invest. 2022.
PMID: 35763353
Free PMC article.
Item in Clipboard
Cite
Cite